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Introduction
Celecoxib is a selective cyclooxygenase-2 (COX-2) inhibitor.
It is frequently associated with several side effects such as
urticaria, anaphylaxis, angio-oedema and erythema multi-
forme. However, bullous eruptions induced by celecoxib
have been rarely described previously. We report an original
case of Celecoxib-induced bullous eruption confirmed by a
positive patch test.
Case report
A 32-year-old woman was referred to the emergency
department because she developed a skin eruption,
pruritis and frisson which have occurred four hours
after the intake of 200mg of celecoxib for inflammatory
back pain. Physical examination revealed generalized
urticaria which was thought to be induced by celecoxib.
Therefore, she was prescribed corticosteroid therapy and
antihistaminic drug and advised to avoid celecoxib.
Three days later, she has returned to the emergency
department because of skin eruption worsening. Physical
examination showed bullous eruption predominantly in
the proximal limbs and the buttock without mucosal
involvement. The body temperature and blood pressure
were normals. The laboratory findings didn’t show any
abnormality. When examining the patient medical his-
tory, we found that she has had developed, three years
ago, a generalized skin eruption two days after celecoxib
intake. Six weeks after total recovery of skin eruption,
patch test to celecoxib (10% in petroleum) was per-
formed, showing a positive reaction at 48h reading. In
order to investigate a possible cross reactivity among
sulfonamide drugs, we carried out a patch test to furose-
mide which was negative at 48h reading.
Conclusion
We add to the medical literature a case of bullous erup-
tion induced by celecoxib, confirmed by a positive skin
test. Clinicians should be aware of such potentially
severe side effect when prescribing this drug.
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